|
Kianmanesh et al.
|
2007
|
37.2 % (16/43)
|
36 vs. 35.3 months
|
No differences between groups
|
|
Only 70 % of patients having CC-0 or CC-1 surgery
|
|
Chua et al.
|
2009
|
29.1 % (16/55)
|
65 vs. 68 %, 2 years
|
No differences between groups
|
|
Group of combined liver and peritoneal, lower PCI (8 vs. 12)
|
|
Varban et al.
|
2009
|
9.9 % (14/142)
|
23 vs. 15.8 months
|
No differences between groups
|
|
43.3 vs. 36.8 %, 2 years
|
Median number and size of liver metastasis: 1 (1–7) and 3 cm (0.4–12)
|
|
Elias et al.
|
2009
|
14.72 % (77/523)
|
21 vs. 27 %, 5 years
|
Multicentric study
|
|
No differences between groups
|
|
Glehen et al.
|
2004
|
12.15 % (61/502)
|
16.8 vs. 20.4 months
|
Liver metastasis as negative predictive factor for OS (p = 0.008)
|
|
Maggiori et al.
|
2013
|
37 vs. 60
|
40 vs. 66 %, 3 years
|
Median OS 40 months for PCI <12 and 1 or 2 liver metastases
|
|
32 vs. 49 months
|
